Study of Pralatrexate to Treat Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
| Status: | Archived |
|---|---|
| Conditions: | Lymphoma |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | September 2009 |
| End Date: | June 2013 |
A Phase 2, Single-arm, Open-label, Multi-center Study of Pralatrexate in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
The purpose of this study is to determine whether pralatrexate, given with vitamin B12 and
folic acid, is effective in the treatment of relapsed or refractory B-cell Non-Hodgkin's
lymphoma (NHL). The study will also investigate the safety of pralatrexate with vitamin B12
and folic acid in this patient population. Additionally, this study includes the collection
of blood samples to investigate the pharmacokinetics (PK) of pralatrexate in this patient
population (PK is the activity of a drug in the body over a period of time, including how
the drug is absorbed, distributed in the body, localized in the tissues, and excreted from
the body).
We found this trial at
11
sites
Rush University Medical Center Rush University Medical Center encompasses a 664-bed hospital serving adults and...
Click here to add this to my saved trials
600 Highland Ave.
Madison, Wisconsin 53792
Madison, Wisconsin 53792
(608) 262-5223
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center UW Carbone Cancer Center holds the...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Gundersen Lutheran Gundersen Health System is where caring meets excellence through a comprehensive health network...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials